11-47347660-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_000256.3(MYBPC3):c.842G>A(p.Arg281Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000286 in 1,573,944 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. R281R) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000256.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYBPC3 | ENST00000545968.6 | c.842G>A | p.Arg281Gln | missense_variant | Exon 8 of 35 | 5 | NM_000256.3 | ENSP00000442795.1 | ||
MYBPC3 | ENST00000399249.6 | c.842G>A | p.Arg281Gln | missense_variant | Exon 8 of 34 | 5 | ENSP00000382193.2 | |||
MYBPC3 | ENST00000544791.1 | n.842G>A | non_coding_transcript_exon_variant | Exon 8 of 27 | 5 | ENSP00000444259.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152050Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000482 AC: 9AN: 186580Hom.: 0 AF XY: 0.0000498 AC XY: 5AN XY: 100354
GnomAD4 exome AF: 0.0000288 AC: 41AN: 1421894Hom.: 0 Cov.: 33 AF XY: 0.0000341 AC XY: 24AN XY: 703614
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152050Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74268
ClinVar
Submissions by phenotype
not provided Uncertain:4
- -
- -
In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 28166811, 21310275, 20800588, 32841044) -
- -
Hypertrophic cardiomyopathy Uncertain:2Benign:1
- -
This missense variant replaces arginine with glutamine at codon 281 of the MYBPC3 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in two individuals affected with hypertrophic cardiomyopathy (PMID: 20800588, 30685992). This variant has been identified in 11/217880 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 281 of the MYBPC3 protein (p.Arg281Gln). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with hypertrophic cardiomyopathy (PMID: 20800588, 30685992). ClinVar contains an entry for this variant (Variation ID: 525001). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiomyopathy Uncertain:1
This missense variant replaces arginine with glutamine at codon 281 of the MYBPC3 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in two individuals affected with hypertrophic cardiomyopathy (PMID: 20800588, 30685992). This variant has been identified in 11/217880 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Hypertrophic cardiomyopathy 4;C3715165:Left ventricular noncompaction 10 Uncertain:1
- -
Cardiovascular phenotype Uncertain:1
The p.R281Q variant (also known as c.842G>A), located in coding exon 8 of the MYBPC3 gene, results from a G to A substitution at nucleotide position 842. The arginine at codon 281 is replaced by glutamine, an amino acid with highly similar properties. This variant was identified in hypertrophic cardiomyopathy cohorts; however, details were not provided (Millat G et al. Clin. Chim. Acta, 2010 Dec;411:1983-91; Nagyova E et al. Bratisl Lek Listy, 2019;120:46-51). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on available evidence to date, the clinical significance of this alteration remains unclear. -
MYBPC3-related disorder Uncertain:1
The MYBPC3 c.842G>A variant is predicted to result in the amino acid substitution p.Arg281Gln. This variant has been reported in individuals with hypertrophic cardiomyopathy (Millat et al. 2010. PubMed ID: 20800588; Nagyova et al. 2019. PubMed ID: 30685992). In one report, a computational assessment interpreted the c.842G>A variant as likely benign (Table S1, Jordan et al. 2011. PubMed ID: 21310275). This variant is reported in 0.0095% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at